Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) Director Esteban Lopez sold 150 shares of the company’s stock in a transaction on Monday, December 15th. The stock was sold at an average price of $115.18, for a total transaction of $17,277.00. Following the sale, the director directly owned 3,700 shares of the company’s stock, valued at approximately $426,166. This represents a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link.
Esteban Lopez also recently made the following trade(s):
- On Friday, December 5th, Esteban Lopez sold 166 shares of Addus HomeCare stock. The stock was sold at an average price of $112.78, for a total transaction of $18,721.48.
Addus HomeCare Stock Down 1.4%
ADUS stock opened at $113.49 on Wednesday. The stock has a market capitalization of $2.10 billion, a price-to-earnings ratio of 24.30, a price-to-earnings-growth ratio of 1.54 and a beta of 0.94. The company has a 50-day moving average of $115.87 and a two-hundred day moving average of $113.84. Addus HomeCare Corporation has a 52-week low of $88.96 and a 52-week high of $136.72. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.66 and a quick ratio of 1.66.
Wall Street Analysts Forecast Growth
Several research analysts have commented on the company. Royal Bank Of Canada lifted their price target on Addus HomeCare from $134.00 to $139.00 and gave the stock an “outperform” rating in a research report on Friday, November 7th. BMO Capital Markets assumed coverage on shares of Addus HomeCare in a research note on Thursday, November 13th. They set a “market perform” rating and a $120.00 target price for the company. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, October 8th. UBS Group began coverage on shares of Addus HomeCare in a report on Tuesday, September 2nd. They set a “buy” rating and a $145.00 price objective on the stock. Finally, Cowen reiterated a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. Eight research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $137.11.
Check Out Our Latest Stock Analysis on ADUS
Hedge Funds Weigh In On Addus HomeCare
Hedge funds and other institutional investors have recently made changes to their positions in the business. Russell Investments Group Ltd. lifted its holdings in Addus HomeCare by 10.1% during the 2nd quarter. Russell Investments Group Ltd. now owns 55,900 shares of the company’s stock valued at $6,439,000 after purchasing an additional 5,110 shares during the last quarter. Nordea Investment Management AB increased its holdings in shares of Addus HomeCare by 0.3% during the second quarter. Nordea Investment Management AB now owns 36,159 shares of the company’s stock worth $4,131,000 after buying an additional 111 shares in the last quarter. Creative Planning raised its stake in shares of Addus HomeCare by 150.9% in the second quarter. Creative Planning now owns 7,024 shares of the company’s stock valued at $809,000 after acquiring an additional 4,224 shares during the last quarter. Maryland State Retirement & Pension System boosted its holdings in shares of Addus HomeCare by 1.9% in the 2nd quarter. Maryland State Retirement & Pension System now owns 5,335 shares of the company’s stock worth $615,000 after acquiring an additional 101 shares in the last quarter. Finally, Loomis Sayles & Co. L P grew its position in Addus HomeCare by 25.2% during the 2nd quarter. Loomis Sayles & Co. L P now owns 101,705 shares of the company’s stock worth $11,715,000 after acquiring an additional 20,479 shares during the last quarter. 95.35% of the stock is owned by institutional investors.
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Further Reading
- Five stocks we like better than Addus HomeCare
- Stock Analyst Ratings and Canadian Analyst Ratings
- 25 Years Later, Cisco Finally Recovers From the Dot-Com Crash
- 5 Top Rated Dividend Stocks to Consider
- AI Chips Can’t Exist Without These 2 Underrated Tech Giants
- The 3 Best Fintech Stocks to Buy Now
- Why Taiwan Semiconductor’s 6.5% Dip Could Be a Smart Buy
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
